Diabetic Medications 2015 - International Conference on Targeting Diabetes and Novel Therapeutics

Being recognized as a world-renowned organization, OMICS Group International takes pride to introduce the commencement of “International Conference on Targeting Diabetes and Novel Therapeutics” from September 14 - 16, 2015 at Las Vegas, Nevada, USA. Special interest and theme of this conference is: “New insights in prevention and management of diabetes through intervening technologies”. The conference aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial professionals in this sphere. OMICS Group’s Diabetic Medications conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research.
OMICS Publishing Group through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Publishing Group hosts over 400 leading-edge peer reviewed Open Access journals and has organized over 300 scientific conferences all over the world.
OMICS Group welcomes all the scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine to attend this Diabetes Conferences, where all the aspects of diabetes will be discussed under single roof. Diabetic Medications-2015 will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.
Diabetic Medications-2015 is an international platform for presenting research about diabetes management and therapeutics, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society. Diabetic Medications-2015 is where the future of management and novel therapeutics for the disease intersects.
Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. As the number of patients grows across the globe, there has never been a stronger and more urgent need for novel therapeutic measures in clinical and preclinical evaluation, that arrest the growth of the disease. The diabetes market, consisting mainly of Type 1 and Type 2 diabetes, is large and growing significantly. The global market value for diabetes therapies and diagnostics has reached to $48.5 billion. The largest segment of the market, insulin products, is worth $20.8 billion in the recent times, including administration and diagnostic devices. Monitoring devices and other related equipment, the second-largest market is established with an investment of $13.5 billion in which was proposed for $11.3. The fastest-growing segment of oral diabetic hypoglycemia drugs manufacturing funding is $14.13 in present scenario of diabetes market. For more...
Why Las Vegas (Nevada)?
Diabetes is the 10th leading cause of death in Nevada (vs. 7th in the United States). Nevada is currently ranked 16th out of all states in diabetes prevalence. In 2010, 7.9% of Nevada’s population reported having been diagnosed with diabetes (over 160,000 people). Although Nevada has been improving its relative position in the state-by-state rankings, diabetes prevalence in Nevada has been increasing over the past 20 years. Estimates are that the total cost of diabetes in Nevada will exceeds $17.3 billion by 2015, including lost work productivity and direct medical bills. About equal percentages of men and women in Nevada have clinically diagnosed diabetes, but men have a higher mortality rate from diabetes than do women. Rates are highest among older Nevadans (aged 55 and older). In terms of race/ethnicity, blacks have the highest diabetes rate and diabetes mortality rate in Nevada while whites have the lowest diagnosis rate and whites and Hispanics have the lowest diabetes mortality rates.
Diabetes Medications
Type-1 Diabetes is normally seen in Children and Young adults. It is caused due to low secretion of insulin. This means the need of regular insulin treatment to keep your glucose levels normal. There's no cure for diabetes, so treatment aims to keep blood glucose levels as normal and to control the symptoms to prevent health problems developing later in life.
The goal is to keep the daytime blood sugar levels before meals between 70 and 130 mg/dL (3.9 to 7.2 mmol/L) and after meal numbers no higher than 180 mg/dL (10 mmol/L) two hours after eating. The global treatment market for Type 1 Diabetes (T1D) will expand from $6.6 billion in 2013 to an estimated $13.6 billion by 2023, representing a Compound Annual Growth Rate (CAGR) of 7.6%, according to research. Primary care of Diabetes, Restoring and maintaining normal pancreas function through Beta Cell Regeneration, Islet transplantation, Genetic Engineering and Recombinant DNA technology approaches are some of the Novel therapeutic targets for diabetes.
Type 2 Diabetes- Therapies and treatments
Type 2 Diabetes is one of the most significant global health concerns of modern times. According to the International Diabetes Federation, more than 317 million people have been diagnosed with diabetes, and an additional 187 million are living undiagnosed. The global revenue earned from drugs sales to treat type 2 diabetes was approximately $36.89 billion in 2012 that is rapidly increasing in incidence and prevalence across the globe predicated to elevate this figure to approximately $68.42 billion by 2017. Patients with this disease cannot use glucose properly for their body needs. Self-monitoring of Blood glucose levels, Lifestyle modifications and Health eating habits are crucial in combating the critical manifestations of this disease which may require proper diabetic nursing. This may also include considerable amount of time educating patients and families on proper dietary, exercise and lifestyle habits to keep symptoms under control.
Alternative Treatment for Diabetes
Diabetes mellitus is a dreadful disease and is found in all parts of the world, becoming a serious threat of mankind health. There are lots of chemical agents available to take control on the disease, but total recovery from diabetes is the question to the treatment. Alternative to these synthetic agents, plants provided a potential source of natural cure of hypoglycemic drugs and are widely used in several traditional systems of medicine to prevent Prediabetes. Other alternative therapies such as Diabetic supplements, acupuncture, hydrotherapy, and yoga therapies are reported to have less likely side effects of conventional approaches for diabetes.
Diabetic Diet and Prevention
With the growing awareness and information regarding preventive measures for combating fatal disease like diabetes, consumers are opting for proper food along with medicines. One can improve the health in a big way by making small changes to the diet, while still enjoying the favorite foods and taking pleasure from the meals. A diabetes diet is simply a healthy eating plan that is high in nutrients, low in fat, and moderate in calories. Manufacturers are now keen on introducing new low calorie food products with sugar substitutes and less oil, in view of the increasing consumer interest toward healthy eating and help prevent diabetes and its concomitant risk factors
Diabetic Cure and Diagnosis
The global diabetes treatment market is undergoing significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. There has been a drastic increase in the incidents of diabetes worldwide, owing to the rising level of lifestyles and obesity in global population. The diabetes treatment products include injectable diabetes drugs, oral drugs, insulin therapies, insulin pumps, insulin injection devices and blood glucose monitoring systems . According to the new report the world market for diabetes medications will reach $55.3bn in 2017. The anti-diabetic medicines industry generated $35.6bn in 2012, and its revenues will show strong growth to 2023. Monitoring glucose levels is critical for the management of diabetes and new and improved portable, less costly, easy-to-use, accurate and virtually painless blood glucose monitoring systems are now available to take control of the disease.
Diabetes Research in Clinical Practice
Novel therapeutic targets available for diabetes includes Incretin based therapies, oral therapeutic agents like secretagogues, beta cell regeneration & proliferation and stem cell therapies. Embryonic stem cell and fetal precursor cell transplantation therapies are the major stem cell therapies available for Diabetes. Apart from the above, various computational approaches in Diabetes management have been introduced recently which are playing an important role in identification of genes causing diabetes helping in Early Detection of Diabetes. These processes are also useful in studying the chemical etiologies of Diabetes uncovering various treatment prospects and model construction processes for survival prediction.
Advanced Medications for Diabetes Complications
With rising numbers of diagnosed diabetics, pharmaceutical manufacturers have capitalized on the burgeoning market for diabetes therapies. Manufacturers' efforts to develop non-invasive methods of insulin delivery are set to revolutionize the insulin therapy market, while demand for oral medications is on the upswing due to a growing type II diabetic population and introduction of technologically advanced therapies. With human embryonic stem cells as a starting point, the scientists are for the first time able to produce, in the kind of massive quantities needed for cell transplantation and pharmaceutical purposes, human insulin-producing beta cells equivalent in most every way to normally functioning beta cells. This will certainly help people recover the prognosis of the fatal disease.
Computational Biology of Diabetes
Computational meta-analysis can link environmental chemicals to genes and proteins involved in human diseases, thereby elucidating possible etiologies. The recent rapid development of a variety of analytical platforms based on mass spectrometry and nuclear magnetic resonance have enabled identification of complex metabolic syndrome phenotypes. Continued development of bioinformatics and analytical strategies has facilitated the discovery of causal links in understanding the pathophysiology of diabetes and its complications.
Recent Research and Advanced Technologies for Diabetes care
Current Research in diabetes is focusing on developing Implantable insulin pumps which introduced Insulin pump therapy, disruption of fat metabolism, invasive and non-invasive glucose sensors, Artificial pancreas, New insulin delivery systems like inhaled, transdermal and implantable devices, Insulin Pens, Bariatric surgery and Conventional therapeutic approaches. Traditional approaches like Acupuncture and herbal medications are playing vital role in treatment of Diabetes.
Risk factors and related diseases of Diabetes
Diabetes is always accompanied by a number of serious health issues. Consistent increase in blood glucose levels can lead to serious diseases affecting the vital organs of body like heart and blood vessels, eyes, kidneys, nerves and teeth. In almost all high-income countries, diabetes is a leading cause of cardiovascular disease like diabetic cardiomyopathy being one of the major risk factor, blindness, kidney failure, and lower limb amputation. Diabetic Retinopathy causes progressive damage to the retina in the patients with diabetes adding as the most vulnerable risk for the patient. Maintaining blood glucose levels, blood pressure, diabetic gastro paresis which has been reported to have the main cause as Diabetes Mellitus and cholesterol at or close to normal can help delay or prevent diabetes complications.